VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 10 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2012. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $223,000 | +22200.0% | 1,121 | +11110.0% | 0.01% | – |
| Q4 2015 | $1,000 | -99.4% | 10 | -99.0% | 0.00% | -100.0% |
| Q3 2015 | $174,000 | -29.8% | 978 | -12.3% | 0.01% | -16.7% |
| Q2 2015 | $248,000 | +11.2% | 1,115 | -0.5% | 0.01% | +20.0% |
| Q1 2015 | $223,000 | +165.5% | 1,121 | +92.0% | 0.01% | +150.0% |
| Q4 2014 | $84,000 | -75.6% | 584 | -77.6% | 0.00% | -71.4% |
| Q1 2014 | $344,000 | +341.0% | 2,610 | +291.3% | 0.01% | +250.0% |
| Q4 2013 | $78,000 | -17.9% | 667 | -26.8% | 0.00% | -33.3% |
| Q3 2013 | $95,000 | +17.3% | 911 | -3.0% | 0.00% | 0.0% |
| Q2 2013 | $81,000 | +9.5% | 939 | -4.3% | 0.00% | +50.0% |
| Q1 2013 | $74,000 | +21.3% | 981 | -3.8% | 0.00% | 0.0% |
| Q4 2012 | $61,000 | +8.9% | 1,020 | 0.0% | 0.00% | 0.0% |
| Q3 2012 | $56,000 | +124.0% | 1,020 | +80.2% | 0.00% | +100.0% |
| Q2 2012 | $25,000 | -37.5% | 566 | -23.8% | 0.00% | 0.0% |
| Q1 2012 | $40,000 | +90.5% | 743 | +61.9% | 0.00% | 0.0% |
| Q4 2011 | $21,000 | +23.5% | 459 | 0.0% | 0.00% | 0.0% |
| Q3 2011 | $17,000 | -10.5% | 459 | +23.7% | 0.00% | 0.0% |
| Q2 2011 | $19,000 | – | 371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |